Reducing compounds initiate the TRP2-catalyzed conversion of L-dopachrome to DHICA.
Rosengren
E
E
Rorsman
H
H
D000111:Acetylcysteine / Q000494:pharmacology; D000818:Animals; D003545:Cysteine / Q000494:pharmacology; D045563:Indolequinones; D007211:Indoles / Q000378:metabolism*; D019746:Intramolecular Oxidoreductases / Q000378:metabolism*; D008546:Melanoma, Experimental / Q000378:metabolism*; D051379:Mice; D010084:Oxidation-Reduction; D011809:Quinones / Q000378:metabolism*; D011817:Rabbits; D019163:Reducing Agents / Q000494:pharmacology*
D045563:Indolequinones; D007211:Indoles; D011809:Quinones; D019163:Reducing Agents; C001123:dopachrome; C030692:5,6-dihydroxy-2-indolylcarboxylic acid; D019746:Intramolecular Oxidoreductases; C042501:dopachrome isomerase; D003545:Cysteine; D000111:Acetylcysteine